CAS: 5616-81-9; Tert-Butyl 2-(Methylamino)Acetate

该化合物是一种多用途有机化合物,通常用作制药和农用化学合成的中间体,其乙丁基酯组群增强了稳定性,便利了处理和储存,而甲基氨基甲基混合物则为进一步的功能化提供了回动性.该化合物因其具有作为受保护的甘油衍生物的能力,对浸泡合成和活性药物成分的制备特别有用.它平衡的亲脂性和在普通有机溶剂中的溶解性使其适合多种反应条件.产品高纯度和一贯的质量确保了复杂的合成途径的可靠性能,支持高效的扩大工艺.

结构式图片

相似化合物

136088-69-2 111652-20-1 107-97-1

欧盟法规

C&L通报

上下游产品

CAS号5292-43-3 溴乙酸叔丁酯 | CAS号74-89-5 氨基甲烷 | CAS号107-59-5 氯乙酸叔丁酯 | CAS号107-97-1 肌氨酸 | CAS号115-11-7 2-甲基丙烯 | CAS号144036-71-5 N-氨基-N-甲基甘氨酸叔丁酯 | CAS号107-97-1 肌氨酸

合成工艺路线路线简述

  • 合成目标产物 Tert-Butyl Sarcosinate Hydrochloride 主要起始原料 Tert-Butyl Bromoacetate And Methylamine
  • (文献来源)合成步骤主要原料 Tert-Butyl Bromoacetate 和 Methylamine
📜(Benzyloxycarbonyl)Sarcosine Tert-Butyl Ester置于palladium On Activated Charcoal 氢气体系中,化学反应生成 肌氨酸叔丁酯盐酸盐
参考文献:使用新型1 H-苯并咪唑鎓盐高效合成含有n-甲基化氨基酸残基的位阻受阻肽
标题:使用新型1 H-苯并咪唑鎓盐高效合成含有n-甲基化氨基酸残基的位阻受阻肽
摘要:设计,合成了新型1 H-苯并咪唑型肽偶联剂cmbi,证明其在促进空间位阻酰胺和酯键形成方面是有效的.通过模型反应试验和成功合成了各种受阻寡肽和含有n-甲基氨基酸残基的肽段,证明了其高效率,其反应速度快,外消旋化程度低且产率高.提出了由试剂介导的酰胺键形成机理.
DOI:10.1016/s0040-4020(00)00963-7

海关参考信息

专利信息


专利号:US-8304409-B2
优先权日:2002-07-03
标 题:Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
发明人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
权利人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI; NICOX SA
摘要:The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.

专利号:US-5021550-A
优先权日:1986-10-07
标 题 :Method for preventing deletion sequences in solid phase synthesis
发明人:ZEIGER ALLEN R
权利人:UNIV JEFFERSON
摘要:Improved methods for solid-state synthesis of polymers, especially polypeptides and polynucleotides, are provided. In accordance with a preferred embodiment, selectively activatable and reactive bonding moieties are covalently bonded to solid supports for polynucleotide and polypeptide syntheses. Products of failed reactions and some side products are caused to react with the selectively activatable and reactive bonding moiety to cause divalent bonding of unwanted products to the solid support. Upon cleavage of the initial situs of covalent bonding to the solid support, desired products are free to be collected while unwanted products remain covalently bonded to the support. Ease of purification of such polymers is a principal object of the present invention. The methods of the invention are amenable to automation and digital control and novel solid supports, activatable, reactive bonding moieties and other compositions are presented. The expression of polynucleotides prepared in accordance with preferred embodiments produces novel polypeptides.

专利号:US-2009099061-A1
优先权日:2006-01-27
标 题:Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics
发明人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
权利人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
摘要:A method is described for synthesizing and administering carotenoid compounds with improved antioxidant characteristics. In some embodiments, extension or improvement of conjugation may be employed in structural modification of carotenoids. In other embodiments, reduction of ring/chain steric hindrance may improve the lambda max, and hence, the overall antioxidant capability, of particular compounds. In other embodiments, introduction and/or increase in synthetic handles for conjugation may improve the stoichiometric ratios of conjugating moieties to the polyene backbone. The methods may be used to improve natural and/or synthetic compounds for medicinal application in the treatment of disease.

专利号:WO-9411388-A1
优先权日:1992-11-06
标题:Support for the synthesis of modular polymers

专利号:US-5310894-A
优先权日:1990-09-11
标题 :Solid phase polynucleotide syntheses
发明人:ZEIGER ALLEN R
权利人:UNIV JEFFERSON
摘要:Methods for solid-state synthesis of polymers, especially polypeptides and polynucleotides, are provided. In accordance with a preferred embodiment, selectively activatable and reactive bonding moieties are covalently bonded to solid supports for polynucleotide and polypeptide syntheses. Products of failed reactions and some side products are caused to react with the selectively activatable and reactive bonding moiety to cause divalent bonding of unwanted products to the solid support. Upon cleavage of the initial situs of covalent bonding to the solid support, desired products are free to be collected while unwanted products remain covalently bonded to the support. Ease of purification of such polymers is a principal object of the present invention. The methods of the invention are amenable to automation and digital control and novel solid supports, activatable, reactive bonding moieties and other compositions are presented. The expression of polynucleotides prepared in accordance with preferred embodiments produces novel polypeptides.

专利号:US-8338565-B2
优先权日:2008-08-20
标 题 :Macrocyclic compounds for inhibition of tumor necrosis factor alpha
发明人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P
权利人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P; ENSEMBLE THERAPEUTICS CORP
摘要:Disclosed herein are macrocyclic compounds and methods for their synthesis and use. In particular, macrocyclic compounds are disclosed that modulate the activity of tumor necrosis factor alpha and/or are useful in the treatment of medical conditions, such as, rheumatoid arthritis, psoriasis, and asthma.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Luckose F, Et Al. Effects Of Amino Acid Derivatives On Physical, Mental, And Physiological Activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

合成参考文献


摘要:Jung, N.; Bräse, S., Science of Synthesis, (2010) 41, 619.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知